292 related articles for article (PubMed ID: 16857415)
21. Screening for familial paragangliomas.
Myssiorek D; Ferlito A; Silver CE; Rodrigo JP; Baysal BE; Fagan JJ; Suárez C; Rinaldo A
Oral Oncol; 2008 Jun; 44(6):532-7. PubMed ID: 17936061
[TBL] [Abstract][Full Text] [Related]
22. Malignant head and neck paragangliomas in SDHB mutation carriers.
Boedeker CC; Neumann HP; Maier W; Bausch B; Schipper J; Ridder GJ
Otolaryngol Head Neck Surg; 2007 Jul; 137(1):126-9. PubMed ID: 17599579
[TBL] [Abstract][Full Text] [Related]
23. [Medullary thyroid carcinoma and some of its particularities].
Sidibé el H
Sante; 2007; 17(1):51-5. PubMed ID: 17897902
[TBL] [Abstract][Full Text] [Related]
24. Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2.
Moore SW; Appfelstaedt J; Zaahl MG
J Pediatr Surg; 2007 Feb; 42(2):326-32. PubMed ID: 17270543
[TBL] [Abstract][Full Text] [Related]
25. A novel mutation in the SDHD gene in a family with inherited paragangliomas--implications of genetic diagnosis for follow up and treatment.
Renard L; Godfraind C; Boon LM; Vikkula M
Head Neck; 2003 Feb; 25(2):146-51. PubMed ID: 12509798
[TBL] [Abstract][Full Text] [Related]
26. Familial risk for neuroendocrine tumors.
Anderson RJ; Lynch HT
Curr Opin Oncol; 1993 Jan; 5(1):75-84. PubMed ID: 8094015
[TBL] [Abstract][Full Text] [Related]
27. Multiple endocrine neoplasia type 2 and sporadic medullary thyroid carcinoma: Turkish experience.
Erdogan MF; Gursoy A
Pediatr Endocrinol Rev; 2006 Aug; 3 Suppl 3():503-7. PubMed ID: 17551473
[TBL] [Abstract][Full Text] [Related]
28. A novel mutation in the SDHD gene responsible for familial paraganglioma. Medical and psychological implications.
Prontera P; Ferrando B; Giuliani V; Falcinelli F; Mencarelli A; Rogaia D; Pasini B; Donti E
Genet Couns; 2008; 19(4):413-8. PubMed ID: 19239085
[TBL] [Abstract][Full Text] [Related]
29. Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-out.
Neumann HP; Erlic Z; Boedeker CC; Rybicki LA; Robledo M; Hermsen M; Schiavi F; Falcioni M; Kwok P; Bauters C; Lampe K; Fischer M; Edelman E; Benn DE; Robinson BG; Wiegand S; Rasp G; Stuck BA; Hoffmann MM; Sullivan M; Sevilla MA; Weiss MM; Peczkowska M; Kubaszek A; Pigny P; Ward RL; Learoyd D; Croxson M; Zabolotny D; Yaremchuk S; Draf W; Muresan M; Lorenz RR; Knipping S; Strohm M; Dyckhoff G; Matthias C; Reisch N; Preuss SF; Esser D; Walter MA; Kaftan H; Stöver T; Fottner C; Gorgulla H; Malekpour M; Zarandy MM; Schipper J; Brase C; Glien A; Kühnemund M; Koscielny S; Schwerdtfeger P; Välimäki M; Szyfter W; Finckh U; Zerres K; Cascon A; Opocher G; Ridder GJ; Januszewicz A; Suarez C; Eng C
Cancer Res; 2009 Apr; 69(8):3650-6. PubMed ID: 19351833
[TBL] [Abstract][Full Text] [Related]
30. Uncommon clinical presentations of pheochromocytoma and paraganglioma in two different patients affected by two distinct novel VHL germline mutations.
Ercolino T; Becherini L; Valeri A; Maiello M; Gaglianò MS; Parenti G; Ramazzotti M; Piscitelli E; Simi L; Pinzani P; Nesi G; Degl'Innocenti D; Console N; Bergamini C; Mannelli M
Clin Endocrinol (Oxf); 2008 May; 68(5):762-8. PubMed ID: 18031321
[TBL] [Abstract][Full Text] [Related]
31. Hereditary cancer and its clinical implications: a view.
Den Otter W; Koten JW; Van der Vegt BJ; Beemer FA; Boxma OJ; De Graaf PW; Derkinderen DJ; Hill FW; Huber J; Klein WR
Anticancer Res; 1990; 10(2B):489-95. PubMed ID: 2190527
[TBL] [Abstract][Full Text] [Related]
32. RET proto-oncogene mutations are restricted to codons 634 and 918 in mainland Chinese families with MEN2A and MEN2B.
Zhou Y; Zhao Y; Cui B; Gu L; Zhu S; Li J; Liu J; Yin M; Zhao T; Yin Z; Yu C; Chen C; Wang L; Xiao B; Hong J; Zhang Y; Tang Z; Wang S; Li X; Ning G
Clin Endocrinol (Oxf); 2007 Oct; 67(4):570-6. PubMed ID: 17573899
[TBL] [Abstract][Full Text] [Related]
33. No germline mutations in CDKN2A (p16) in patients with squamous cell cancer of the head and neck and second primary tumours.
Jefferies S; Edwards SM; Hamoudi RA; A'Hern R; Foulkes W; Goldgar D; Eeles R;
Br J Cancer; 2001 Nov; 85(9):1383-6. PubMed ID: 11720478
[TBL] [Abstract][Full Text] [Related]
34. Genetic mutations in thyroid carcinoma.
Taccaliti A; Boscaro M
Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
[TBL] [Abstract][Full Text] [Related]
35. [Hereditary endocrine tumour diseases].
Husebye ES; Varhaug JE; Heimdal K
Tidsskr Nor Laegeforen; 2005 Nov; 125(21):2964-7. PubMed ID: 16276382
[TBL] [Abstract][Full Text] [Related]
36. Clinical and molecular progress in hereditary paraganglioma.
Baysal BE
J Med Genet; 2008 Nov; 45(11):689-94. PubMed ID: 18978332
[TBL] [Abstract][Full Text] [Related]
37. [Hereditary pheochromocytoma and paraganglioma].
Musil Z; Vícha A; Zelinka T; Turková H; Labudová T; Kohoutová M; Pacák K
Klin Onkol; 2012; 25 Suppl():S21-6. PubMed ID: 22920202
[TBL] [Abstract][Full Text] [Related]
38. Inherited predisposition to cancer: a historical overview.
Lynch HT; Shaw TG; Lynch JF
Am J Med Genet C Semin Med Genet; 2004 Aug; 129C(1):5-22. PubMed ID: 15264268
[TBL] [Abstract][Full Text] [Related]
39. SDHC mutation in an elderly patient without familial antecedents.
López-Jiménez E; de Campos JM; Kusak EM; Landa I; Leskelä S; Montero-Conde C; Leandro-García LJ; Vallejo LA; Madrigal B; Rodríguez-Antona C; Robledo M; Cascón A
Clin Endocrinol (Oxf); 2008 Dec; 69(6):906-10. PubMed ID: 18681855
[TBL] [Abstract][Full Text] [Related]
40. Neurofibromatosis type 1: should we screen for other genetic syndromes? A case report of co-existence with multiple endocrine neoplasia 2A.
Gkaliagkousi E; Erlic Z; Petidis K; Semertzidis P; Doumas M; Zamboulis C; Neumann HP; Douma S
Eur J Clin Invest; 2009 Sep; 39(9):828-32. PubMed ID: 19558618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
